What is the normal free thyroxine (FT4) value in a 3-month-old baby using the Vidas Enzyme-Linked Chemiluminescent Immunoassay (ECLIA) method?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Free Thyroxine (FT4) Values for 3-Month-Old Infants Using ECLIA Method

The normal FT4 reference range for a 3-month-old infant using the ECLIA (electrochemiluminescence immunoassay) method is not specifically established in the available evidence, but pediatric reference ranges for young children (4-6 years) show FT4 values of 1.12-1.67 ng/dL (14.4-21.5 pmol/L) using the ECLusys ECLIA method 1.

Age-Specific Considerations for Infant FT4 Values

  • Infants have significantly different thyroid hormone levels compared to older children and adults, making age-appropriate reference ranges critical for accurate interpretation 1.

  • The youngest age group with established ECLIA reference ranges in the available evidence is 4-6 years, with FT4 values of 1.12-1.67 ng/dL using the ECLusys ECLIA method 1.

  • Neonatal screening studies using dried blood spots show mean FT4 concentrations of 20-22 pg/mL on days 5-6 of life, with 97.8% of values between 10-35 pg/mL 2.

Critical Limitations and Clinical Approach

  • Method-specific reference ranges are essential, as FT4 values calculated from different assay methods can vary by up to 30%, making it impossible to apply reference ranges from one method to another 3.

  • The ECLIA method (specifically ECLusys kits) has established pediatric reference ranges starting at age 4 years, but no published reference ranges exist for infants under 4 years using this specific methodology 1.

  • Using adult reference ranges for pediatric patients can lead to misdiagnosis of hypothyroidism or oversight of subclinical thyroid dysfunction 1.

Practical Recommendations for Clinical Interpretation

  • Contact your laboratory directly to obtain their method-specific reference range for 3-month-old infants, as each laboratory should establish age-appropriate reference ranges for their specific assay platform 1.

  • If laboratory-specific infant ranges are unavailable, TSH measurement is more reliable than FT4 alone for screening thyroid dysfunction in infants, with combined TSH and FT4 measurement providing optimal diagnostic accuracy 2.

  • Neonatal hypothyroidism is definitively diagnosed when FT4 is markedly suppressed (typically <6.2 pg/mL in dried blood spots) with TSH >99 μU/mL 2.

Common Pitfalls to Avoid

  • Never apply adult FT4 reference ranges (0.7-1.8 ng/dL or 9-23 pmol/L) to infants, as this will result in diagnostic errors 1, 3.

  • Do not assume reference ranges are transferable between different ECLIA platforms or manufacturers, even when using the same analytical principle 3.

  • Avoid interpreting FT4 values in isolation—always correlate with TSH and clinical presentation, as FT4 alone has lower diagnostic sensitivity for hypothyroidism compared to TSH 2, 4.

Related Questions

Which laboratory test is ordered to measure free thyroxine and what is its abbreviation (FT4)?
What is the normal reference range for Free Thyroxine (FT4) in children under 1 month, measured in nanograms per deciliter (ng/dL)?
Is the normal range of free thyroxine (FT4) in a 3-month-old baby using the Electrochemiluminescence Immunoassay (ECLIA) (Vidas) method between 0.8 and 2.1 ng/dL?
What is the normal reference range for Free Thyroxine (FT4) in infants aged 8-13 days in ng/dL?
Can a patient with normal Thyroid-Stimulating Hormone (TSH) and slightly elevated Free Thyroxine (FT4) be cleared for surgery?
What is the recommended driving pressure (DP) for mechanical ventilation in conditions like Acute Respiratory Distress Syndrome (ARDS)?
What is the possible diagnosis for a patient with reddish-brown itchy patches and non-palpable purpura on the foot, thighs, back, and abdomen?
What is the diagnosis and treatment approach for adenocarcinoma (adenocarcinoma) that is positive for pankeratin (pankeratin) and CK7 (cytokeratin 7), but negative for TTF1 (thyroid transcription factor 1), CDX2 (caudal type homeobox 2), PSA (prostate-specific antigen), and CK20 (cytokeratin 20)?
What to do with atorvastatin (statin) therapy when Alanine Transaminase (ALT) and Aspartate Transaminase (AST) levels are elevated but do not exceed 3 times the Upper Limit of Normal (ULN)?
What is the recommended first line therapy protocol for acne treatment, including application timing and duration?
What is the best course of action for a pregnant woman at 38 weeks gestation with a breech presentation and 4cm dilation, showing no change after 2 hours with a reactive Cardiotocography (CTG)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.